NordicNeuroLab of Bergen, Norway, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its nordicICE Perfusion/Dynamic Contrast Enhanced (DCE) module.
The approval clears the Perfusion/DCE module for analysis of MR perfusion and contrast agent permeability.
Related Reading
NordicNeuroLab gets FDA nod for fMRI modules, December 1, 2008
Road to RSNA, Advanced Visualization, NordicNeuroLab, November 6, 2008
NordicImagingLab releases nordicICE 2.3, July 21, 2008
NordicNeuroLab nets 510(k) for new software, June 3, 2008
NordicNeuroLab forms U.S. office, April 16, 2008
Copyright © 2009 AuntMinnie.com
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
